Mr. Krysiak is a strong business leader with 17 years of biopharmaceutical industry experience focused on rare diseases and oncology. Currently, he serves as the President & CEO of Seva Therapeutics, an innovative oncology company. His previous experience includes CEO of 3G Therapeutics, VP of Sales and Business Development at EmpiraMed, VP of Commercial and Operations at Ceerdis Corporation, Area Director & GM at BioMarin Pharmaceuticals, as well as progressive sales and marketing management roles at Genzyme Corporation. Mr. Krysiak started his career in general and specialty sales at Merck.
Mr. Krysiak obtained a B.S. in both Biomedical Sciences and Biochemistry from the University of Guelph and a M.S. in Molecular Physiology from the University of Western Ontario. He has also received executive business training from the Ivey Business School.